Shattuck Labs (STTK) Cash from Investing Activities (2019 - 2026)

Shattuck Labs (STTK) reported Cash from Investing Activities of $23.8 million for Q1 2026, up 52.87% year-over-year from $15.6 million in Q1 2025, and up 19.24% on a QoQ basis from $20.0 million in Q4 2025.

Shattuck Labs (STTK) has 8 years of Cash from Investing Activities data on file, last reported at $23.8 million in Q1 2026.

  • Quarterly Cash from Investing Activities rose 52.87% year-over-year to $23.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $361000.0 (down 99.11% YoY) and the FY2025 annual result came in at -$7.9 million, up 7.33% from the prior year.
  • Cash from Investing Activities rose to $23.8 million in Q1 2026 per STTK's latest filing, from $20.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $55.9 million in Q4 2023 and bottomed at -$43.5 million in Q3 2025.
  • The 5-year median for Cash from Investing Activities is $17.8 million (2025), against an average of $10.5 million.
  • The widest annual swing landed in 2023, when Cash from Investing Activities surged 611.71%; it then slumped 5196.83% in 2025.
  • Tracing STTK's Cash from Investing Activities over 5 years: stood at $31.5 million in 2022, then soared by 77.52% to $55.9 million in 2023, then sank by 44.5% to $31.0 million in 2024, then tumbled by 35.48% to $20.0 million in 2025, then grew by 19.24% to $23.8 million in 2026.
  • Per Business Quant, the three latest STTK Cash from Investing Activities figures stand at $23.8 million (Q1 2026), $20.0 million (Q4 2025), and -$43.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -2.89 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -25.54 Mn
10 Shattuck Labs 667.80 Mn 667.80 Mn - 23.85 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 23.85 Mn
Mar 31, 2026 23.85 Mn
Dec 31, 2025 20.00 Mn
Dec 31, 2025 20.00 Mn
Sep 30, 2025 -43.49 Mn
Sep 30, 2025 -43.49 Mn
Mar 31, 2025 15.60 Mn
Mar 31, 2025 15.60 Mn
Dec 31, 2024 31.00 Mn
Dec 31, 2024 31.00 Mn
Sep 30, 2024 -821,000.00
Sep 30, 2024 -821,000.00
Jun 30, 2024 -5.41 Mn
Jun 30, 2024 -5.41 Mn
Mar 31, 2024 -33.28 Mn
Mar 31, 2024 -33.28 Mn
Dec 31, 2023 55.85 Mn
Dec 31, 2023 55.85 Mn
Sep 30, 2023 -14.55 Mn
Sep 30, 2023 -14.55 Mn
Jun 30, 2023 24.43 Mn
Jun 30, 2023 24.43 Mn
Mar 31, 2023 45.13 Mn
Mar 31, 2023 45.13 Mn
Dec 31, 2022 31.46 Mn
Dec 31, 2022 31.46 Mn
Sep 30, 2022 29.93 Mn
Sep 30, 2022 29.93 Mn
Jun 30, 2022 3.43 Mn
Jun 30, 2022 3.43 Mn
Mar 31, 2022 -15.38 Mn
Mar 31, 2022 -15.38 Mn
Dec 31, 2021 25.60 Mn
Dec 31, 2021 25.60 Mn
Sep 30, 2021 11.24 Mn
Sep 30, 2021 11.24 Mn
Jun 30, 2021 14.84 Mn
Jun 30, 2021 14.84 Mn
Mar 31, 2021 -62.13 Mn
Mar 31, 2021 -62.13 Mn
Dec 31, 2020 -171.49 Mn
Dec 31, 2020 -171.49 Mn
Sep 30, 2020 9.99 Mn
Sep 30, 2020 9.99 Mn
Jun 30, 2020 8.48 Mn
Jun 30, 2020 8.48 Mn
Mar 31, 2020 6.70 Mn
Mar 31, 2020 6.70 Mn
Dec 31, 2019 -530,000.00
Dec 31, 2019 -530,000.00